02.05.2012 • NewsConocoPhillipsPhillips 66Petrochemicals

ConocoPhillips Completes Spin-off of Refining Business

ConocoPhillips completed the spin-off of Phillips 66, its refining, marketing, chemicals and transportation arm, creating the newest independent U.S. refiner.

Phillips 66 aims to focus on growth in its midstream and chemical segments, more than double shale oil run at its refineries to 460,000 barrels per day and double refined product exports to 200,000 barrels per day within two years.

The spin-off completion came a day after ConocoPhillips agreed to sell its 185,000 barrel-per-day (bpd) refinery in Trainer, Pennsylvania, to Delta Air Lines for $150 million. The deal is expected to close in the first half of 2012.

Phillips 66 also is marketing its 247,000 bpd Alliance refinery in Belle Chasse, Louisiana. Including Trainer, the company owns or has an interest in 11 U.S. refineries, three in Europe and one in Asia.

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.